News
- Author:
- Nancy A. Melville
Publish date: October 11, 2021
The drugs were linked to improvements in Graves’ orbitopathy, even in people without high LDL-cholesterol.
News
- Author:
- Nancy A. Melville
Publish date: September 24, 2021
“These diseases do not choose an arbitrary side in the pelvis ... Instead, [they] affect the entire pelvis and require a multidisciplinary and coll...
News
- Author:
- Nancy A. Melville
Publish date: September 21, 2021
Studies showing a linear dose-response risk warrant further research, but overall assessment of risks called “reassuring.”
News
- Author:
- Nancy A. Melville
Publish date: September 16, 2021
In the first update since 2010, the North American Menopause Society addresses new advances, including use of novel agents to prevent “bone attacks...
News
- Author:
- Nancy A. Melville
Publish date: September 1, 2021
“The new paradigm calls for identifying, through molecular analysis, the cancers that have the ability to respond to RAI and/or those that cou...
News
- Author:
- Nancy A. Melville
Publish date: August 25, 2021
“Repeated alcohol consumption events even at lower amounts of alcohol may have a greater carcinogenic effect on G...
News
- Author:
- Nancy A. Melville
Publish date: August 24, 2021
In an updated recommendation, the USPSTF lowers the screening age for prediabetes and diabetes from 40 to 35 year...
News
- Author:
- Nancy A. Melville
Publish date: August 24, 2021
Shortcomings in datasets, particularly for women of African descent, hinder their clinical use. Efforts to...
News
- Author:
- Nancy A. Melville
Publish date: August 16, 2021
The latest wealth and debt report shows few changes; gender disparities in wealth are notable.
News
- Author:
- Nancy A. Melville
Publish date: August 13, 2021
A meta-analysis that incorporates the most recent research on the topic shows important benefits of a low glycemic diet for people with diabetes.
News
- Author:
- Nancy A. Melville
Publish date: July 28, 2021
Although ACE inhibitors are more commonly prescribed, new findings from almost 3 million patients support starting with ARBs as first-time treatmen...
News
- Author:
- Nancy A. Melville
Publish date: July 22, 2021
The fixed-dose dolutegravir-based regimen shows noninferiority versus any ART regimens, while also showing feasibility as a first-line treatment in...
News
- Author:
- Nancy A. Melville
Publish date: July 21, 2021
Mortality from cryptococcal meningitis with a single-dose regimen of liposomal amphotericin B is similar to the lo...
News
- Author:
- Nancy A. Melville
Publish date: July 21, 2021
“According to its long half-life of two subcutaneous injections per year, [it] could help reduce pill burden.”
News
- Author:
- Nancy A. Melville
Publish date: July 19, 2021
Lower doses of linezolid in the BPaL regimen reduce the adverse events in patients with highly dru...
